Get started
Author

Jaime Sanz

Observed names: J Sanz, J. Sanz, J. Sanz Caballer, J. Sanz-Caballer, Jaime Sanz Caballer, Jaime Sanz-Caballer, Jamie Sanz, Jorge Hernando Sanz, Miguel Á. Sanz, Sanz, Jaime
Institutions: Memorial Sloan Kettering Cancer Center, Universitat de València, Instituto de Salud Carlos III, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red, Centro de Investigación Biomédica en Red de Cáncer, Instituto de Investigación Sanitaria La Fe
Observed institutions: Universitat Autònoma de Barcelona, University of Minnesota, Memorial Sloan Kettering Cancer Center, Roslin Institute, The University of Texas MD Anderson Cancer Center, Universitat de València, Aix-Marseille Université, Instituto de Salud Carlos III, Hammersmith Hospital, Hospital de Sant Pau, Hospital Universitari i Politècnic La Fe, Grupo Español de Trasplante Hematopoyético y Terapia Celular, Institut universitaire du cancer de Toulouse Oncopole, Hôpital Saint-Antoine, Institut Català d'Oncologia, Hospital Clínica Benidorm, Hospital Regional Universitario de Málaga, Centro Nacional de Sanidad Ambiental, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Duran i Reynals Hospital, Hôpital Saint-Louis, Institut Paoli-Calmettes, INCLIVA Health Research Institute, Centro de Investigación Biomédica en Red de Cáncer, European Society for Blood and Marrow Transplantation, Instituto de Investigación Sanitaria La Fe, Laboratoire Management Sport Cancer, Imperial College London, Universidad Carlos III de Madrid, Columbia University, University of Edinburgh
ORCID: 0000-0001-6934-4619
Observed ORCID: 0000-0001-6934-4619
OpenAlex ID: A5040307230
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation
2020 · Eolia Brissot, Myriam Labopin, et al. · Bone Marrow Transplantation · 660
PDF
Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model
2007 · P. Montesinos, I. Lorenzo, et al. · Haematologica · 231
PDF
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3
2024 · Mark J. Levis, Mehdi Hamadani, et al. · Journal of Clinical Oncology · 223
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
2015 · A Ruggeri, M Labopin, et al. · Leukemia · 216
Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
2020 · Alexandros Spyridonidis, Myriam Labopin, et al. · Bone Marrow Transplantation · 207
PDF
Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
2008 · Celso A. Rodrigues, Guillermo Sanz, et al. · Journal of Clinical Oncology · 201
Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen
2012 · J Sanz, J C H Boluda, et al. · Bone Marrow Transplantation · 140
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
2022 · Mi Kwon, Gloria Iacoboni, et al. · Haematologica · 136
PDF
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
2020 · Ali Bazarbachi, Gesine Bug, et al. · Haematologica · 136
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
2020 · Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Jaime Sanz, et al. · Journal of Hematology & Oncology · 122
PDF
Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide Therapy vs Other Donor Transplantations in Adults With Hematologic Cancers
2019 · Nico Gagelmann, Andrea Bacigalupo, et al. · JAMA Oncology · 113
PDF
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT
2013 · A Ruggeri, G Sanz, et al. · Leukemia · 99
Bone Marrow-Derived Cells from Male Donors Do Not Contribute to the Endometrial Side Population of the Recipient
2012 · Irene Cervelló, Claudia Gil-Sanchis, et al. · PLoS ONE · 99
PDF
Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients
2007 · J Sanz, F Arriaga, et al. · Bone Marrow Transplantation · 99
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study
2019 · On behalf of the Grupo Español de Trasplante Hematopoyético (GETH), Virginia Escamilla Gómez, et al. · Bone Marrow Transplantation · 87
Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae
2022 · Ana Djukovic, María José Garzón, et al. · Nature Communications · 84
PDF
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation
2012 · Thomas Daikeler, Myriam Labopin, et al. · Blood · 80
PDF
Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia
2009 · Jaime Sanz, Miguel A. Sanz, et al. · Transplantation and Cellular Therapy · 79
PDF
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
2014 · Jan M. Middeke, Min Fang, et al. · Blood · 73
Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
2020 · Ali Bazarbachi, Christoph Schmid, et al. · Clinical Cancer Research · 72
PDF
Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation
2006 · Noemí Puig, Javier De La Rubia, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 71
EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases
2013 · J Sanz, M Arango, et al. · Bone Marrow Transplantation · 69
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
2020 · Eolia Brissot, Myriam Labopin, et al. · Journal of Hematology & Oncology · 68
PDF
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen
2014 · A. Ruggeri, M. Labopin, et al. · Haematologica · 65
PDF
Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico
2015 · Guillermo Orti, Jaime Sanz, et al. · Transplantation and Cellular Therapy · 64
PDF
Works count: 419
Citation count: 7,324
H-index: 44
I10-index: 148
Year
Topic
Type